HOWL (STOCKS)
Werewolf Therapeutics, Inc. Common Stock
$0.945500
+0.096500 (+11.37%)
Prev close: $0.849000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Daniel J. Hicklin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $44.25M
- Employees
- 39
- P/E (TTM)
- -0.69
- P/B (TTM)
- 1.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.17 | $-0.35 | +0.1819 | +51.69% |
|
Sep 2025 (Q3)
|
$-0.36 | $-0.40 | +0.0378 | +9.50% |
|
Jun 2025 (Q2)
|
$-0.40 | $-0.49 | +0.0855 | +17.61% |
|
Mar 2025 (Q1)
|
$-0.40 | $-0.40 | +0.0019 | +0.47% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$145.00K |
| Operating Expenses | $60.68M |
| Research and Development | $44.83M |
| Other Operating Expenses | $15.85M |
| Operating Income/Loss | -$60.68M |
| Income/Loss From Continuing Operations After Tax | -$60.82M |
| Income/Loss From Continuing Operations Before Tax | -$60.82M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$60.82M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$60.82M |
| Net Income/Loss Available To Common Stockholders, Basic | -$60.82M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.32 |
| Diluted Earnings Per Share | -$1.33 |
| Basic Average Shares | 46,018,888 |
| Diluted Average Shares | 46,810,252 |
| Assets | $69.40M |
| Current Assets | $58.59M |
| Noncurrent Assets | $10.81M |
| Fixed Assets | $4.69M |
| Other Non-current Assets | $6.12M |
| Liabilities | $44.59M |
| Current Liabilities | $36.15M |
| Accounts Payable | $754.00K |
| Wages | $302.00K |
| Other Current Liabilities | $35.09M |
| Noncurrent Liabilities | $8.44M |
| Long-term Debt | $32.09M |
| Equity | $24.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $24.81M |
| Liabilities And Equity | $69.40M |
| Net Cash Flow From Operating Activities | -$60.29M |
| Net Cash Flow From Operating Activities, Continuing | -$60.29M |
| Net Cash Flow From Investing Activities | $54.26M |
| Net Cash Flow From Investing Activities, Continuing | $54.26M |
| Net Cash Flow From Financing Activities | $6.03M |
| Net Cash Flow From Financing Activities, Continuing | $6.03M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$60.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$60.82M |
| Other Comprehensive Income/Loss | $0.00 |